Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 961-970 of 2787 for

Edit search filters
  1. A Study of ABC294640 (Yeliva®) in the Treatment of Patients with Advanced Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study of AP160-Complex in Advanced Solid Tumors

    Rochester, MN

  3. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

    Rochester, MN

  4. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. STI-3031 Through Sofusa DoseConnect for Treatment of Intransit Melanoma

    Jacksonville, FL, Rochester, MN

  6. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab

    Jacksonville, FL

  7. Ease Aromatase Inhibitor-induced Musculoskeletal Symptoms

    Rochester, MN

  8. Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

    Rochester, MN

  9. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer

    Jacksonville, FL

  10. A Study to Assess Accelerated Resolution Therapy for Cancer Related Trauma and Distress

    Jacksonville, FL

.

Mayo Clinic Footer